Qiaoqing Zhong, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Body Surface Area | 1 | 2024 | 207 | 0.890 |
Why?
|
| Peripheral Arterial Disease | 1 | 2024 | 1299 | 0.420 |
Why?
|
| PPAR gamma | 1 | 2015 | 487 | 0.390 |
Why?
|
| Lipoproteins, HDL | 1 | 2015 | 682 | 0.350 |
Why?
|
| Databases, Factual | 1 | 2024 | 8081 | 0.310 |
Why?
|
| Adipocytes | 1 | 2015 | 1199 | 0.290 |
Why?
|
| Body Mass Index | 1 | 2024 | 13030 | 0.270 |
Why?
|
| Obesity | 1 | 2024 | 13065 | 0.200 |
Why?
|
| Pancreatitis, Acute Necrotizing | 1 | 2022 | 174 | 0.180 |
Why?
|
| Digoxin | 1 | 2020 | 246 | 0.160 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2019 | 394 | 0.150 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2023 | 614 | 0.140 |
Why?
|
| Diabetic Foot | 1 | 2019 | 383 | 0.130 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2020 | 775 | 0.130 |
Why?
|
| Vascular Surgical Procedures | 1 | 2024 | 1509 | 0.130 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2020 | 383 | 0.120 |
Why?
|
| Inflammasomes | 1 | 2019 | 541 | 0.120 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2019 | 507 | 0.120 |
Why?
|
| Profilins | 1 | 2013 | 65 | 0.110 |
Why?
|
| Cardiomegaly | 1 | 2016 | 591 | 0.110 |
Why?
|
| 3T3 Cells | 1 | 2015 | 1086 | 0.110 |
Why?
|
| Adipokines | 1 | 2015 | 309 | 0.100 |
Why?
|
| Interleukin-8 | 1 | 2015 | 705 | 0.100 |
Why?
|
| Lipoproteins, LDL | 1 | 2015 | 644 | 0.100 |
Why?
|
| DNA Copy Number Variations | 1 | 2020 | 2046 | 0.090 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2015 | 797 | 0.090 |
Why?
|
| Endovascular Procedures | 1 | 2024 | 2258 | 0.090 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2019 | 1671 | 0.080 |
Why?
|
| Oxidation-Reduction | 1 | 2015 | 2232 | 0.080 |
Why?
|
| Autophagy | 1 | 2016 | 1349 | 0.070 |
Why?
|
| Mitochondria | 1 | 2020 | 3672 | 0.070 |
Why?
|
| Interleukin-6 | 1 | 2015 | 3234 | 0.060 |
Why?
|
| Time Factors | 2 | 2024 | 40271 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2019 | 3805 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2024 | 24311 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2024 | 15880 | 0.050 |
Why?
|
| Manikins | 1 | 2023 | 254 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2024 | 65409 | 0.040 |
Why?
|
| Hyperandrogenism | 1 | 2020 | 46 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 59680 | 0.040 |
Why?
|
| Metagenomics | 1 | 2022 | 476 | 0.040 |
Why?
|
| Sirtuin 1 | 1 | 2019 | 247 | 0.040 |
Why?
|
| Interleukin-18 | 1 | 2019 | 251 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 18048 | 0.040 |
Why?
|
| Risk Factors | 1 | 2024 | 74915 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2023 | 1095 | 0.030 |
Why?
|
| United States | 1 | 2024 | 73121 | 0.030 |
Why?
|
| Heart Failure | 1 | 2020 | 11857 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2024 | 81834 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2019 | 10784 | 0.030 |
Why?
|
| Aged | 2 | 2024 | 171520 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2019 | 1021 | 0.030 |
Why?
|
| China | 1 | 2020 | 2398 | 0.030 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2019 | 1121 | 0.030 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2020 | 1066 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 1518 | 0.030 |
Why?
|
| Dyslipidemias | 1 | 2020 | 874 | 0.030 |
Why?
|
| Middle Aged | 2 | 2024 | 223418 | 0.020 |
Why?
|
| Mice | 2 | 2019 | 82045 | 0.020 |
Why?
|
| Humans | 8 | 2024 | 768451 | 0.020 |
Why?
|
| Male | 3 | 2024 | 364781 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 2016 | 986 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2022 | 3665 | 0.020 |
Why?
|
| Arginine | 1 | 2013 | 923 | 0.020 |
Why?
|
| Female | 3 | 2024 | 396943 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2013 | 1133 | 0.020 |
Why?
|
| Animals | 3 | 2019 | 169418 | 0.020 |
Why?
|
| Heart | 1 | 2023 | 4451 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2023 | 3805 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2013 | 1207 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2019 | 3520 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2013 | 1179 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2019 | 3145 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2016 | 1683 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2022 | 14728 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2020 | 3941 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2020 | 3974 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2020 | 5620 | 0.020 |
Why?
|
| Transfection | 1 | 2013 | 5767 | 0.020 |
Why?
|
| Antioxidants | 1 | 2013 | 1678 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2013 | 2150 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2013 | 2491 | 0.020 |
Why?
|
| RNA Interference | 1 | 2013 | 2832 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2013 | 2146 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 11930 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2016 | 23638 | 0.010 |
Why?
|
| Hypertension | 1 | 2020 | 8611 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2013 | 12813 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2013 | 19041 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 5709 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 18388 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 12242 | 0.010 |
Why?
|
| Mutation | 1 | 2020 | 30243 | 0.010 |
Why?
|